Pinato, D. J., Marron, T. U., Mishra-Kalyani, P. S., Gong, Y., Wei, G., Szafron, D., Sharon, E., Saeed, A., Jun, T., Dharmapuri, S., Naqash, A. R., Peeraphatdit, T., Gampa, A., Wang, Y., Khan, U., Muzaffar, M., Navaid, M., Lee, C. J., Lee, P., Bulumulle, A., Yu, B., Paul, S., Nimkar, N., Bettinger, D., Hildebrand, H., Abugabal, Y. I., Pressiani, T., Personeni, N., D'Alessio, A., Kaseb, A. O., Huang, Y., Ang, C., Schneider, J., Pillai, A., Rimassa, L., Goldberg, K. B., Pazdur, R., Theoret, M., Lemery, S., Fashoyin-Aje, '., Cortellini, A., & Pelosof, L. (2021). treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice. European journal of cancer, 157, 140–152. http://access.bl.uk/ark:/81055/vdc_100144519838.0x00001f